Experts discussed advancements in dermatology treatment while emphasizing the value of in-person collaboration and professional rejuvenation at the American Academy of Dermatology 2025 conference.

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking ...

March 7, 2025 /PRNewswire/ -- Four new officers and four new board members will be installed immediately upon conclusion of the 2025 Annual Meeting of the American Academy of Dermatology.

Patients with atopic dermatitis (AD) who achieve completely clear skin with tapinarof (Vtama) cream maintain low disease ...

ORLANDO, FL (March 7, 2025) — Philadelphia-based board-certified dermatologist Susan C. Taylor, MD, FAAD, will begin her one-year term as president of the American Academy of Dermatology at the close ...

Skin care has spawned some of social media’s biggest stars, many of whom have lucrative deals with companies to promote their ...

ORLANDO — Seemal R. Desai, MD, FAAD, who is finishing his term as American Academy of Dermatology president, took time to reflect on his own leadership journey and inspire future leaders at the ...

Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...

Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research SessionMarlborough, Massachusetts--(Newsfile ...

Larry Eichenfield, M.D., chief of pediatric and adolescent dermatology at Rady Children's Hospital, presented a session at ...

Taylor, MD, FAAD, will begin her one-year term as president of the American Academy of Dermatology at the close of the AAD's Annual Meeting. Dr. Taylor will lead the world's largest dermatologic ...